• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Biofourmis

Biofourmis Secures $300M to Expand Virtual Care Offerings

by Digital Health Funding 04/26/2022 Leave a Comment

Biofourmis Secures $300M to Expand Virtual Care Offerings

What You Should Know: - Biofourmis, a global leader in virtual care and digital medicine raises $300 million in Series D investment led by leading global growth equity firm General Atlantic. CVS Health and existing investors also participated in the round, - Biofourmis also announced that former Medtronic CEO and Chairperson at Intel, Dr. Omar Ishrak, will join the company’s Board of Directors as Chairman. Transforming Patient Health Through Personalized, Predictive Care Founded in
Read More

Powered by Biofourmis, Blessing Health System Partners Launches Home Hospital Services

by Partnerships 03/31/2022 Leave a Comment

What You Should Know: - Blessing Health System, an integrated rural health system selects Biofourmis, a virtual care and digital therapeutics provider to launch its own home hospital services. - As part of the selection, Biofourmis is supporting the health system with its turnkey, end-to-end, home hospital solution for participation in the Rural Home Hospital project.  Delivering Acute-Level Hospital Care Inside Patients’ Homes This new program allows caregivers to
Read More

Biofourmis Earns FDA Breakthrough Device Designation for Digital Therapeutic for Heart Failure

by Fred Pennic 07/30/2021 Leave a Comment

Biofourmis Earns FDA Breakthrough Device Designation for Digital Therapeutic for Heart Failure

What You Should Know: - Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced its BiovitalsHF® solution is the first-ever heart failure digital therapeutic to receive a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). - The Breakthrough Devices Program was created to provide patients and providers with timely access to medical devices (in this case, software as a medical device, or SaMD) by speeding up their
Read More

30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021

by Fred Pennic 12/30/2020 Leave a Comment

30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021

As we close out the year, we asked several healthcare executives to share their predictions and trends for 2021. Kimberly Powell, Vice President & General Manager, NVIDIA Healthcare Federated Learning: The clinical community will increase their use of federated learning approaches to build robust AI models across various institutions, geographies, patient demographics, and medical scanners. The sensitivity and selectivity of these models are outperforming AI models
Read More

Brigham, Biofourmis Co-Develops Tech Solution to Enable Home Hospital Care

by Jasmine Pennic 12/03/2020 Leave a Comment

Brigham, Biofourmis Co-Develops Tech Solution to Enable Home Hospital Care

What You Should Know: - Brigham is working with Biofourmis on a national rollout of their co-developed technology solution, which has been refined and scaled for use by other healthcare systems across the country seeking to establish and execute similar home hospital programs to alleviate COVID-related capacity issues and to receive 1:1 parity on payments from CMS. - The Hospital@HomeTM platform provides a turnkey, end-to-end ecosystem for any health system that wants to quickly launch
Read More

Biofourmis Lands $100M to Expand AI-Powered Digital Therapeutics Platform

by Fred Pennic 09/03/2020 Leave a Comment

Biofourmis Lands $100M to Expand AI-Powered Digital Therapeutics Platform

What You Should Know: - Boston-based digital therapeutics leader Biofourmis just closed a $100 million Series C funding round led by SoftBank, bringing its total funding to $145M.   - Biofourmis will be using the funding to develop, validate and commercialize several released and unreleased digital therapeutics solutions across cardiology, oncology, respiratory, and pain, with a focus on the United States and key Asian markets, including Asia Pacific, China, and
Read More

Biofourmis Acquires Digital Therapeutics Oncology Startup Gaido Health

by Fred Pennic 04/16/2020 Leave a Comment

Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health

What You Should Know: - Boston-based digital therapeutics startup Biofourmis acquires LA-based Gaido Health from Takeda Pharmaceuticals, in a strategic deal that expands Biofourmis’ portfolio in the oncology space. - Gaido Health—a digital therapeutics company focused on the oncology market—was part of Takeda Digital Ventures, Takeda’s corporate technology investment and incubation arm. - With Gaido Health’s and Biofourmis’ dual focus on remote monitoring with wearables
Read More

What Health IT Thought Leaders Say HIMSS20 Would Have Focused On—If It Had Happened

by Jasmine Pennic 03/13/2020 Leave a Comment

Coronavirus Forces Cancellation of 2020 HIMSS Conference: 6 Things to Know

What You Need to Know: Health IT thought leaders share what HIMSS20 would have focused On—if It had happened. - Hot topics include health IT to address COVID-19; artificial intelligence; EHR interoperability and usability; and more. –Kuldeep Singh Rajput, CEO of Biofourmis, Boston, Mass., which provides digital therapeutics that power personalized predictive care “Remote monitoring platforms and clinical-grade wearables combined with artificial intelligence [AI]-based
Read More

Hong Kong’s Dept. of Health Taps Biofourmis’ Remote Monitoring Platform to Fight Coronavirus

by Fred Pennic 03/04/2020 Leave a Comment

Hong Kong’s Dept. of Health Taps Biofourmis’ Remote Monitoring Platform to Fight Coronavirus

What You Need to Know: - Boston-based Biofourmis’ AI-powered digital therapeutics technology has inked a deal with The University of Hong Kong and Hong Kong’s Department of Health to leverage its wearable, AI-powered remote monitoring platform to provide new insights to fight COVID-19 in a national disease monitoring program. - Biofourmis’ technology will remotely monitor coronavirus infected and suspected patients and apply personally predictive analytics to help patients and increase
Read More

Analysis: November 2019 Health IT M&A Activity, Public Company Performance

by Healthcare Growth Partners (HGP) 12/06/2019 Leave a Comment

Analysis: November 2019 Health IT M&A Activity, Public Company Performance

– Healthcare Growth Partners' (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of November 2019We did a doubletake when we noticed all of the HGP healthcare indices climbed approximately 10% during the month of November.  Year-to-date, the S&P 500 is up over 25% and the HGP healthcare indices are all hovering in that range.  In the two month period since September, when talk of universal healthcare reached
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |